Patents by Inventor Rajesh KOMATI

Rajesh KOMATI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • S6K1 PROTEIN KINASE INHIBITORS AS CANCER THERAPEUTICS
    Publication number: 20240158351
    Abstract: The present disclosure relates to compounds that act as protein kinase inhibitors, especially RPS6K1 and the synthesis of the same. Further, the present disclosure teaches the utilization of such compounds in a treatment for proliferative diseases, including cancer, particularly breast cancer, and especially ER+ and/or HER2+ breast cancer, prostate cancer, lung cancer, and metastatic cancer.
    Type: Application
    Filed: December 15, 2023
    Publication date: May 16, 2024
    Inventors: Jayalakshmi SRIDHAR, Melyssa BRATTON, Rajesh KOMATI
  • S6K1 protein kinase inhibitors as cancer therapeutics
    Patent number: 11912660
    Abstract: The present disclosure relates to compounds that act as protein kinase inhibitors, especially RPS6K1 and the synthesis of the same. Further, the present disclosure teaches the utilization of such compounds in a treatment for proliferative diseases, including cancer, particularly breast cancer, and especially ER+ and/or HER2+ breast cancer, prostate cancer, lung cancer, and metastatic cancer.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: February 27, 2024
    Assignee: Xavier University of Louisiana
    Inventors: Jayalakshmi Sridhar, Melyssa Bratton, Rajesh Komati
  • S6K1 PROTEIN KINASE INHIBITORS AS CANCER THERAPEUTICS
    Publication number: 20210323919
    Abstract: The present disclosure relates to compounds that act as protein kinase inhibitors, especially RPS6K1 and the synthesis of the same. Further, the present disclosure teaches the utilization of such compounds in a treatment for proliferative diseases, including cancer, particularly breast cancer, and especially ER+ and/or HER2+ breast cancer, prostate cancer, lung cancer, and metastatic cancer.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 21, 2021
    Inventors: Jayalakshmi SRIDHAR, Melyssa BRATTON, Rajesh KOMATI